Shots:Rami spoke about study design of the P-III study evaluating its lead candidate in migraineMarija Geertsen talked about different treatment options available for migraine & neurological diseasesThe interview highlights the development plans and global expansion of various therapies for brain diseasesSmriti: Explain the details (MOA, ROA, formulations, etc.) of Vyepti.Rami Apelian: VYEPTI®…
